Goldman Sachs
EYPT icon

Goldman Sachs’s EyePoint Pharmaceuticals EYPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.1M Sell
1,280,692
-250,864
-16% -$2.36M ﹤0.01% 2135
2025
Q1
$8.3M Sell
1,531,556
-130,865
-8% -$709K ﹤0.01% 2366
2024
Q4
$12.4M Buy
1,662,421
+447,093
+37% +$3.33M ﹤0.01% 2165
2024
Q3
$9.71M Buy
1,215,328
+423,820
+54% +$3.39M ﹤0.01% 2289
2024
Q2
$6.89M Sell
791,508
-47,970
-6% -$417K ﹤0.01% 2390
2024
Q1
$17.4M Buy
839,478
+271,492
+48% +$5.61M ﹤0.01% 1648
2023
Q4
$13.1M Sell
567,986
-32,488
-5% -$751K ﹤0.01% 1870
2023
Q3
$4.8M Buy
600,474
+173,423
+41% +$1.39M ﹤0.01% 2497
2023
Q2
$3.72M Sell
427,051
-275,531
-39% -$2.4M ﹤0.01% 2783
2023
Q1
$2.07M Sell
702,582
-60,207
-8% -$177K ﹤0.01% 3192
2022
Q4
$2.67M Sell
762,789
-89,916
-11% -$315K ﹤0.01% 3073
2022
Q3
$6.75M Sell
852,705
-34,927
-4% -$276K ﹤0.01% 2424
2022
Q2
$6.99M Buy
887,632
+16,531
+2% +$130K ﹤0.01% 2405
2022
Q1
$10.6M Buy
871,101
+249,083
+40% +$3.03M ﹤0.01% 2190
2021
Q4
$7.61M Buy
622,018
+582,925
+1,491% +$7.14M ﹤0.01% 2478
2021
Q3
$407K Sell
39,093
-204,045
-84% -$2.12M ﹤0.01% 4497
2021
Q2
$2.19M Buy
243,138
+105,301
+76% +$947K ﹤0.01% 3440
2021
Q1
$1.4M Buy
+137,837
New +$1.4M ﹤0.01% 3675
2020
Q4
Sell
-122,975
Closed -$64K 4665
2020
Q3
$64K Sell
122,975
-19,240
-14% -$10K ﹤0.01% 4291
2020
Q2
$107K Buy
142,215
+48,923
+52% +$36.8K ﹤0.01% 4162
2020
Q1
$96K Buy
93,292
+12,589
+16% +$13K ﹤0.01% 4174
2019
Q4
$125K Buy
80,703
+20,001
+33% +$31K ﹤0.01% 4102
2019
Q3
$109K Buy
60,702
+20,582
+51% +$37K ﹤0.01% 4037
2019
Q2
$66K Sell
40,120
-272,649
-87% -$449K ﹤0.01% 4060
2019
Q1
$560K Buy
312,769
+271,169
+652% +$486K ﹤0.01% 3519
2018
Q4
$79K Buy
41,600
+8,264
+25% +$15.7K ﹤0.01% 3926
2018
Q3
$119K Sell
33,336
-9,176
-22% -$32.8K ﹤0.01% 3917
2018
Q2
$88K Buy
+42,512
New +$88K ﹤0.01% 4020
2017
Q4
Sell
-11,693
Closed -$14K 4188
2017
Q3
$14K Buy
11,693
+1,402
+14% +$1.68K ﹤0.01% 4218
2017
Q2
$18K Buy
+10,291
New +$18K ﹤0.01% 4342
2016
Q3
Sell
-20,290
Closed -$57K 4570
2016
Q2
$57K Sell
20,290
-2,412
-11% -$6.78K ﹤0.01% 4250
2016
Q1
$61K Sell
22,702
-3,926
-15% -$10.5K ﹤0.01% 4162
2015
Q4
$128K Sell
26,628
-50,732
-66% -$244K ﹤0.01% 3917
2015
Q3
$282K Sell
77,360
-41,311
-35% -$151K ﹤0.01% 3640
2015
Q2
$447K Sell
118,671
-2,251
-2% -$8.48K ﹤0.01% 3421
2015
Q1
$478K Sell
120,922
-9,000
-7% -$35.6K ﹤0.01% 3342
2014
Q4
$534K Buy
129,922
+122,804
+1,725% +$505K ﹤0.01% 3329
2014
Q3
$31K Buy
+7,118
New +$31K ﹤0.01% 4422